Business · 12/07/2019

FDA Releases Draft Guidance on Hormonal Contraceptive Drug Products

The US Food and Drug Administration (FDA) has published a draft guidance document outlining key design considerations for clinical trials of hormonal drug products intended to prevent pregnancy, aiming to facilitate the development of new and improved contraceptive medications.